A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
about
Gallbladder Cancer in the 21st Century.Advances in chemotherapy for pancreatic cancerTargeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesGemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsEGFR expression in gallbladder carcinoma in North America.Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinomaGemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in JapanGemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective studyOutcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.Chemotherapy and targeted therapy for gall bladder cancer.Guidelines for chemotherapy of biliary tract and ampullary carcinomasPrecision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.Current management of gallbladder carcinoma.Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic ReviewAntitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cellsA phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cellsCholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Impact of medical and surgical intervention on survival in patients with cholangiocarcinomaTargeted therapy for biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.Therapeutical concepts and results for Klatskin tumorsThe role of chemotherapy in biliary tract carcinoma.Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma.KAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Long-term survival of a recurrent gallbladder carcinoma patient with lymph node and peritoneal metastases after multidisciplinary treatments: a case report.Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.Surgery and chemotherapy for intrahepatic cholangiocarcinoma.Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
P2860
Q26784174-06648A3E-76CD-48D9-9E94-A287E6C6DD2EQ28085711-B5DEB491-F92F-4FB5-B5FE-91952BA00DA4Q30234532-100CBC91-8EDF-4DC8-ADE6-60B82F3C762DQ30300756-62E9F6F2-2528-4A11-AD88-6864946FA786Q30318857-0B05D79A-12D1-4B74-AF2E-4D5E8CDE3761Q33372792-4774CBAF-A004-44A9-94B6-9A06295182D7Q33375557-091519FC-D6BB-4918-A346-69C7944AA3DCQ33383423-A37AF85E-7917-4D2A-98DF-28F330222305Q33390747-7C82E55B-531C-422B-A7DF-CA85C3096AC2Q33391003-E74BF61E-86FD-4F05-B69F-67956CD7B91AQ33394065-B831BD6A-BC4B-49AA-B555-0E43DD4411ECQ33402129-B2B37E14-AA61-48F9-8CB1-ABE05531B1B1Q33430668-6B4BB33A-374E-41E0-93CC-99B0A1CF5960Q33435024-345B383D-3EA9-4278-9E80-32A902209475Q33977171-E249404D-50A6-4801-B730-E546D679DFB7Q34588361-AC75C8F3-0D0E-48B7-939C-4658B52A48DBQ34623728-E3E818FA-94A6-4818-9B81-28E6B9C669ABQ34982545-0351404B-D3F8-4536-8556-488F5B9E1ED0Q35429914-704994E2-5BB4-4A12-B5F9-B29F4A28434EQ35583920-D3CC4AD0-65FE-4BE2-A512-81224978F91AQ35871195-FD01C068-2DAE-44CF-BB41-D5FAD913ECF7Q36094595-32A66FF0-C304-4AD4-8CEC-E7776431A5A6Q36459140-263B461C-3924-45DF-A2D7-1786FE39DB24Q36822722-5E66D408-D4BA-4854-8D6F-E091D682C46EQ36962011-E4DDD5C4-679B-43BA-9EC4-19EB13CBEFFBQ37112614-4B18D451-5F25-4B78-9DC9-D5442F95B1D1Q37132750-54E1BB74-D90B-4389-9DB8-5F20640AAF4BQ37138732-67236FD3-3979-4463-A91C-5AB61D6749D4Q37228433-2F67EB93-F341-476B-BDE6-53EA98BA6703Q37261360-1B163C89-397C-44D7-8EB5-A77991CED6FBQ37362900-FE4924A1-F6F6-4929-858F-EAECA7A414F8Q37452157-0CAB37A8-F48D-41C9-A586-AC905C500EA2Q37983498-44D54B80-4F5E-40CC-9F48-73FEBC0A6968Q38372400-7DC74661-D349-4F69-9237-B08A1B2FABCEQ39313846-40C87AE7-3610-496B-96BA-5929DCD9D87DQ39589946-76DF25B1-4125-4491-BCF8-91779564956FQ39987553-82810F46-E950-423D-A63C-9BF376A0D5DEQ41140456-DB8C0057-CE6A-4B00-B9F8-60B9B59EB67CQ42202283-CD11C206-D9D7-4333-BCA1-10BF04061616Q43589273-69D3AD02-90CA-47FD-89C9-4ED9EDE82B67
P2860
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@en
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@nl
type
label
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@en
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@nl
prefLabel
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@en
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@nl
P2093
P2860
P356
P1433
P1476
A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
@en
P2093
Jeeyun Lee
Jin-Seok Heo
Jong Kyun Lee
Joon Oh Park
Keunchil Park
Kyu Taek Lee
Seong-Ho Choi
Seung Tai Kim
Won Ki Kang
Young Suk Park
P2860
P304
P356
10.1002/CNCR.21741
P407
P577
2006-03-01T00:00:00Z